Although hospitals and health systems do not closely track medical errors and misdiagnoses, these issues have begun to receive serious scrutiny. Evidence points to the need for immediate improvement ...

In medicine, the greatest challenges often emerge – not from what healthcare organizations fail to do, but from the variations in how they do it. At MultiCare Health System, a 13-hospital network ...

The clinical decision support space within the broader healthcare AI market is getting more and more crowded, with startups spawning a plethora of tools that help clinicians complete a variety of ...

Please provide your email address to receive an email when new articles are posted on . Patients on the clinical decision support system had greater systolic blood pressure change. Mean systolic blood ...

SAN CARLOS, Calif. & WATERLOO, Ontario--(BUSINESS WIRE)--Onc.AI, a digital health company developing AI-driven oncology clinical management solutions, today announced it has been awarded a $2 million ...

Please provide your email address to receive an email when new articles are posted on . The intervention reduced patients’ mean systolic BP by 14.6 mm HG. However, there was no difference between the ...

Clinical decision support systems are intended to provide clinicians assistance at the point of care, but a new study in the Journal of the American Medical Informatics Association suggests these ...

Dr. Eve Cunningham is group vice president and chief of virtual care and digital health at health system Providence and founder of MedPearl. And Providence is getting ready to spin off MedPearl.

The addition of a clinical decision support tool improved the systolic blood pressure (SBP) among patients with chronic kidney disease and uncontrolled hypertension, according to a new study published ...

The emergence of large language models (LLMs) prompted one research team to compare how well this technology performs compared with traditional clinical decision support systems in identifying ...

STONY BROOK, NY / ACCESSWIRE / June 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a global leader in PCR-based DNA technologies, today announced that its molecular diagnostics ...